EU may consider deal on Merck's COVID pill after approval procedure begins -source

The European Union may consider signing a supply deal with U.S. drugmaker Merck for its experimental COVID-19 pill, but only after the company starts the process of seeking approval for the drug in the bloc, a senior EU official said on Tuesday. The oral antiviral treatment molnupiravir has been developed with Ridgeback Biotherapeutics.